FDA Updates FAQs and Publishes New Web Content about Testing for SARS-CoV-2 and CMS Issues New Rule for SARS-CoV-2 Laboratory Test Result Reporting

COLA is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our COLA laboratories and affiliates. Below are links to the most recent messages on FDA FAQ updates and new FDA web content about testing for SARS-CoV-2 and new CMS rules for SARS-CoV-2 laboratory test result reporting.

Laboratory Update: FDA Updates FAQs and Publishes New Web Content about Testing for SARS-CoV-2

On August 24, 2020, The U.S. Food and Drug Administration (FDA) updated the Frequently Asked Questions (FAQs)external icon about testing for SARS-CoV-2 to include information about screening asymptomatic individuals for COVID-19:

Read more here.

Laboratory Alert: CMS Issues New Rule for SARS-CoV-2 Laboratory Test Result Reporting

On August 25, 2020, the Centers for Medicare & Medicaid Services (CMS) released a new Interim Final Rulepdf iconexternal icon with a Comment Period (CMS-3401-IFC). The new rule describes:

Read more here.